PRF Technologies (PRFX) Common Equity (2019 - 2025)

PRF Technologies (PRFX) posted quarterly Common Equity of $9.3 million for Q4 2025, up 409.32% year-on-year from $1.8 million in Q4 2024, and up 10.03% on a QoQ basis from $8.4 million in Q2 2025.

PRF Technologies (PRFX) Common Equity (2019 - 2025) Analysis & Trends

PRF Technologies (PRFX) has reported Common Equity for 7 consecutive years, with $9.3 million the latest figure, recorded in Q4 2025.

  • Quarterly Common Equity rose 409.32% year-over-year to $9.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.3 million (up 409.32% YoY) and the FY2025 annual result came in at $9.3 million, up 409.32% from the prior year.
  • Common Equity improved to $9.3 million in Q4 2025 per PRFX's latest filing, from $8.4 million in the prior quarter.
  • Over the last five years, Common Equity for PRFX reached as high as $20.4 million in Q1 2021 and fell as low as -$2.0 million in Q2 2024.
  • A 5-year average of $10.8 million and a median of $9.3 million in 2025 frame the typical range for Common Equity.
  • Annual changes were most pronounced in 2024 — Common Equity slumped 129.27% — and 2025, when it soared 513.67%.
  • Year by year, Common Equity stood at $18.1 million in 2021, then tumbled by 39.05% to $11.0 million in 2022, then slumped by 34.32% to $7.2 million in 2023, then slumped by 74.8% to $1.8 million in 2024, then jumped by 409.32% to $9.3 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods registered $9.3 million, $8.4 million, and $1.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 21.93 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 8.23 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 3.23 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 47.38 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 5.90 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 56.13 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 14.66 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 3.41 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.50 Bn
10 PRF Technologies 745,168.93 451,168.93 - 9.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 9.29 Mn
Jun 30, 2025 8.44 Mn
Dec 31, 2024 1.82 Mn
Jun 30, 2024 -2.04 Mn
Mar 31, 2024 1.85 Mn
Dec 31, 2023 7.24 Mn
Sep 30, 2023 8.64 Mn
Jun 30, 2023 6.97 Mn
Mar 31, 2023 8.89 Mn
Dec 31, 2022 11.02 Mn
Sep 30, 2022 13.42 Mn
Jun 30, 2022 15.20 Mn
Mar 31, 2022 16.70 Mn
Dec 31, 2021 18.08 Mn
Sep 30, 2021 19.48 Mn
Jun 30, 2021 19.01 Mn
Mar 31, 2021 20.40 Mn
Dec 31, 2020 16.62 Mn
Jun 30, 2020 -14.16 Mn
Dec 31, 2019 -12.24 Mn